Tanya Stojkovic

Long-term observational study of sporadic inclusion body myositis

Olivier Benvéniste, Marguerite Guiguet, John Freebody et al. · Brain · 2011 · 305 citations · Full text

Effect of ascorbic acid in patients with Charcot–Marie–Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial

Joëlle Micallef, Shahram Attarian, O. Dubourg et al. · The Lancet Neurology · 2009 · 131 citations

Ascorbic Acid, Dental Disease, Placebo-controlled Trial +2

An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

Shahram Attarian, Jean‐Michel Vallat, Laurent Magy et al. · Orphanet Journal of Rare Diseases · 2014 · 124 citations · Full text

FSHD1 and FSHD2 form a disease continuum

Sabrina Sacconi, Audrey Briand‐Suleau, Marilyn Gros et al. · Neurology · 2019 · 83 citations · Full text

MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue

Émilie Capel, Camille Vatier, Pascale Cervera et al. · Journal of clinical lipidology · 2018 · 75 citations · Full text

Inflammation, Metabolic Disorder, Adipose Tissue +4